Food Fortification and Supplementation — MCQs
Which of the following is NOT a core component of the WHO's global STI control strategy?
At what age is the first dose of Measles vaccination given under the Universal Immunization Programme (UIP)?
A primigravida presents to you with anemia early in her pregnancy. She is 7 weeks pregnant as seen on ultrasound. Her hemoglobin level is 9 g/dL. When should the iron supplements be started for her?
Which one of the following is NOT a Voluntary Health Agency?
What is the recommended therapeutic supplementation of iron and folic acid for adults with deficiency?
A patient with homocystinuria presents with ectopia lentis (dislocation of the lens). Which vitamin should be supplemented?
What is the primary health concern addressed by the Rashtriya Bal Swasthya Karyakram (RBSK)?
A family consumes only polished rice. Which of the following combinations of vitamin deficiency and enzymatic defect will be present in this family?
Due to a measles outbreak in a community, a medical officer decided to immunize a child aged seven months with measles vaccine. When should the next measles vaccine be administered?
As per the Government of India guidelines, the daily dose of elemental iron recommended for prophylaxis during pregnancy is
Food Fortification and Supplementation Indian Medical PG Practice Questions and MCQs
Question 1: Which of the following is NOT a core component of the WHO's global STI control strategy?
- A. Case management
- B. Universal mandatory screening (Correct Answer)
- C. Strategic information systems
- D. Prevention services
Explanation: ***Universal mandatory screening*** - While screening is part of STI control, **universal mandatory screening** for all STIs in the general population is not a core component of the WHO's strategy due to feasibility, cost, and ethical considerations. - The strategy emphasizes **targeted screening** for at-risk populations and opportunistic screening. *Case management* - **Case management**, including accurate diagnosis and effective treatment, is a critical component for managing current infections and preventing further transmission. - This involves syndromic or etiologic approaches to treatment and partner notification. *Strategic information systems* - **Strategic information systems** are essential for monitoring trends, evaluating interventions, and informing policy decisions related to STI control. - This includes surveillance data, program monitoring, and research. *Prevention services* - **Prevention services** are a cornerstone of the WHO's strategy, aiming to reduce the incidence of new infections. - These services encompass health education, condom promotion and distribution, vaccination, and pre-exposure prophylaxis (PrEP).
Question 2: At what age is the first dose of Measles vaccination given under the Universal Immunization Programme (UIP)?
- A. 10 weeks
- B. 9 months (Correct Answer)
- C. 14 weeks
- D. 6 months
Explanation: ***9 months*** - The first dose of the **Measles-Rubella (MR) vaccine** is given at **9 months of age** as per India's Universal Immunization Programme (UIP). - This timing is chosen because **maternal antibodies** against measles, which can interfere with vaccine effectiveness, generally wane by this age. - A second dose is given at **16-24 months** to ensure adequate protection (Note: Some countries use MMR vaccine which includes mumps component as well). *10 weeks* - This age is associated with the administration of other routine vaccinations like **Pentavalent vaccine (DPT-HepB-Hib)** and **OPV/IPV**, not measles. - Administering the measles vaccine too early, when **maternal antibodies** are still high, leads to suboptimal immune response. *14 weeks* - This is when the **third dose of Pentavalent vaccine and OPV/IPV** are given as part of the routine immunization schedule. - This age is not the standard recommendation for initial measles vaccination. *6 months* - While specific high-risk situations (e.g., outbreaks or travel to endemic areas) might warrant an additional measles vaccine dose at 6 months, it is **not the routine recommended age** for the first dose. - At 6 months, there may still be sufficient **maternal antibodies** to interfere with vaccine efficacy, leading to poorer immune response compared to vaccination at 9 months. - If given at 6 months during outbreaks, the child still receives routine doses at 9 months and 16-24 months.
Question 3: A primigravida presents to you with anemia early in her pregnancy. She is 7 weeks pregnant as seen on ultrasound. Her hemoglobin level is 9 g/dL. When should the iron supplements be started for her?
- A. 8 to 10 weeks
- B. Immediately upon diagnosis (Correct Answer)
- C. After 14 weeks
- D. After 20 weeks
Explanation: ***Correct Option: Immediately upon diagnosis*** - **Iron deficiency anemia** in pregnancy (Hb <11 g/dL in first trimester) should be addressed promptly to prevent adverse maternal and fetal outcomes - Initiating treatment at 7 weeks ensures sustained **iron stores** throughout pregnancy - WHO and ACOG guidelines recommend **immediate supplementation** when anemia is diagnosed during antenatal screening - Early treatment prevents worsening due to physiological plasma volume expansion in second trimester *Incorrect Option: 8 to 10 weeks* - Delaying treatment for 1-3 weeks after diagnosis at 7 weeks is not justified medically - Any delay in treatment allows anemia to worsen and depletes maternal iron stores - Recommended practice is **immediate supplementation** if hemoglobin count is less than 11 g/dL during first two antenatal visits *Incorrect Option: After 14 weeks* - Waiting until second trimester (after 14 weeks) would allow the **anemia to worsen**, making it harder to correct before physiological drop in hemoglobin due to plasma volume expansion - Fetal development, particularly **neurological development**, is rapid in first trimester and iron is crucial during this period - Delaying 7 weeks after diagnosis risks maternal complications and suboptimal fetal development *Incorrect Option: After 20 weeks* - Starting supplementation this late (13 weeks after diagnosis) would result in severe maternal iron deficiency - Significant **fetal iron demands** increase by third trimester, making it difficult to replete maternal stores if supplementation starts this late - **Severe anemia** poses risks such as **preterm birth**, low birth weight, and **postpartum hemorrhage**
Question 4: Which one of the following is NOT a Voluntary Health Agency?
- A. Ford Foundation
- B. Indian Council for Child Welfare
- C. National Institute of Nutrition (Correct Answer)
- D. Family Planning Association of India
Explanation: ***National Institute of Nutrition*** - The **National Institute of Nutrition (NIN)** is a **government-funded research institute** and is therefore not classified as a voluntary health agency. - NIN is primarily involved in **nutrition research**, policy recommendations, and public health initiatives under the aegis of the Indian Council of Medical Research (ICMR). *Ford Foundation* - The **Ford Foundation** is a global private foundation and, similar to voluntary health agencies, operates with a **philanthropic mission** to promote human welfare. - It provides **grants and support** to various organizations, including those focused on health and social development. *Indian Council for child Welfare* - The **Indian Council for Child Welfare (ICCW)** is a non-governmental organization dedicated to the **welfare of children** in India. - It is a **voluntary health agency** that works on programs related to child health, education, and protection. *Family planning Association of India* - The **Family Planning Association of India (FPAI)** is a well-known **voluntary health agency** that focuses on sexual and reproductive health. - It provides **family planning services**, education, and advocacy, operating on a non-profit and voluntary basis.
Question 5: What is the recommended therapeutic supplementation of iron and folic acid for adults with deficiency?
- A. 20 mg iron, 500 mcg folic acid
- B. 40 mg iron, 250 mcg folic acid
- C. 100 mg iron, 500 mcg folic acid (Correct Answer)
- D. 100 mg iron, 100 mcg folic acid
Explanation: ***100 mg iron, 500 mcg folic acid*** - For adults with **iron deficiency anemia**, the therapeutic dose of elemental iron is typically **100-200 mg daily**, commonly given as ferrous sulfate 325 mg (containing ~65 mg elemental iron) 2-3 times daily. **100 mg is an appropriate therapeutic dose**. - For **folic acid deficiency**, the standard therapeutic dose is **1-5 mg (1000-5000 mcg) daily** for treating established deficiency. However, **500 mcg (0.5 mg)** represents a minimal therapeutic/high prophylactic dose that may be used in milder deficiencies or as initial supplementation. Among the given options, this is the most appropriate combination. *20 mg iron, 500 mcg folic acid* - **20 mg of iron** is grossly insufficient for therapeutic supplementation in iron deficiency anemia and would fail to correct the anemia adequately. - While 500 mcg folic acid has some therapeutic value, the **iron dose is far too low** for treatment. *40 mg iron, 250 mcg folic acid* - **40 mg of iron** is a prophylactic dose (used in pregnancy or prevention) but is **insufficient for therapeutic correction** of established iron deficiency anemia. - **250 mcg of folic acid** is also a prophylactic dose and inadequate for treating established deficiency. *100 mg iron, 100 mcg folic acid* - **100 mg of iron** is an appropriate therapeutic dose for treating **iron deficiency anemia**. - However, **100 mcg of folic acid** is purely a maintenance/prophylactic dose found in multivitamins and is **grossly insufficient** for treating established folic acid deficiency.
Question 6: A patient with homocystinuria presents with ectopia lentis (dislocation of the lens). Which vitamin should be supplemented?
- A. Vitamin B12
- B. Vitamin B6 (Correct Answer)
- C. Thiamine
- D. Vitamin B9 (Folate)
- E. Vitamin C
Explanation: ***Vitamin B6*** - Many cases of **homocystinuria** are due to a deficiency in **cystathionine beta-synthase (CBS)**, an enzyme that requires **pyridoxal phosphate (active B6)** as a cofactor. - Supplementing with **high doses of vitamin B6** can significantly improve outcomes in patients with **B6-responsive homocystinuria** by increasing residual CBS enzyme activity. *Vitamin B12* - While vitamin B12 (cobalamin) is a cofactor for **methionine synthase**, an enzyme involved in homocysteine metabolism, it is not the primary treatment for **homocystinuria due to CBS deficiency**. - B12 deficiency can lead to increased homocysteine levels, but B12 supplementation alone will not address the underlying enzyme defect in most cases of homocystinuria. *Thiamine* - **Thiamine (Vitamin B1)** is essential for carbohydrate metabolism and nerve function, but it has no direct role in the metabolic pathway involved in homocystinuria. - Thiamine deficiency causes **beriberi** and **Wernicke-Korsakoff syndrome**, symptoms distinctly different from homocystinuria. *Vitamin B9 (Folate)* - **Folate** is a cofactor for **methionine synthase**, working alongside vitamin B12 to convert homocysteine back to methionine. - While folate deficiency can contribute to hyperhomocysteinemia, it is not the primary therapeutic intervention for homocystinuria caused by **CBS deficiency**. *Vitamin C* - **Vitamin C (ascorbic acid)** is important for collagen synthesis and acts as an antioxidant, but it has no role in homocysteine metabolism or the treatment of homocystinuria. - Vitamin C deficiency causes **scurvy**, which presents with bleeding gums, petechiae, and poor wound healing—completely unrelated to homocystinuria.
Question 7: What is the primary health concern addressed by the Rashtriya Bal Swasthya Karyakram (RBSK)?
- A. Adult chronic diseases
- B. Elderly health
- C. Non-communicable diseases in the youth
- D. Comprehensive healthcare for children from birth to 18 years (Correct Answer)
Explanation: **Comprehensive healthcare for children from birth to 18 years** - The **Rashtriya Bal Swasthya Karyakram (RBSK)** is a national program explicitly designed to provide comprehensive health screening and early intervention for 0-18 year-olds - Its focus is on detecting and managing the **4 D's**: Defects at birth, Deficiencies, Diseases, and Developmental delays - The program provides regular health check-ups, early detection of health conditions, referral for treatment, and promotes healthy development across this critical age group *Adult chronic diseases* - While public health initiatives address adult chronic diseases, they are not the primary focus of the **RBSK** program, which targets a younger demographic - Programs like the **National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases & Stroke (NPCDCS)** are more aligned with adult chronic disease management *Elderly health* - **RBSK** is specifically focused on the health of children and adolescents, not the elderly population - **National Programme for Healthcare of the Elderly (NPHCE)** is a dedicated initiative for elderly health *Non-communicable diseases in the youth* - While **RBSK** does address some non-communicable diseases (NCDs) through early detection and management, its scope is much broader, encompassing all 4 D's - RBSK aims for **holistic child health** rather than exclusively targeting NCDs in youth, which is a subset of its overall mandate
Question 8: A family consumes only polished rice. Which of the following combinations of vitamin deficiency and enzymatic defect will be present in this family?
- A. Thiamine-transketolase (Correct Answer)
- B. Riboflavin-glutathione reductase
- C. Thiamine-transaminase
- D. Riboflavin-transketolase
Explanation: ***Thiamine-transketolase*** - Consumption of **polished rice** is a classic cause of **thiamine (vitamin B1) deficiency** because the polishing process removes the outer layers of the grain where thiamine is abundant. - **Transketolase** is a key enzyme in the **pentose phosphate pathway** that requires thiamine pyrophosphate (TPP) as a cofactor, making its activity a reliable indicator of thiamine status. *Riboflavin-glutathione reductase* - **Glutathione reductase** activity is indeed used to assess **riboflavin (vitamin B2) status**, as it requires FAD (a derivative of riboflavin) as a cofactor. - However, **riboflavin deficiency** is not characteristically associated with consumption of polished rice. *Thiamine-transaminase* - While this option correctly identifies **thiamine**, the associated enzyme, **transaminase**, is incorrect in this context. - **Transaminases** are primarily dependent on **pyridoxal phosphate (vitamin B6)** as a cofactor, not thiamine. *Riboflavin-transketolase* - This option incorrectly combines **riboflavin deficiency** with the enzyme **transketolase**. - As mentioned, **transketolase** activity is specifically used to assess **thiamine status**, not riboflavin status.
Question 9: Due to a measles outbreak in a community, a medical officer decided to immunize a child aged seven months with measles vaccine. When should the next measles vaccine be administered?
- A. Not required
- B. When the child completes nine months of age (Correct Answer)
- C. When the child completes fifteen months of age
- D. After four weeks
Explanation: ***When the child completes nine months of age*** - A measles vaccine given at **seven months during an outbreak** is considered a **zero-dose** or **early dose** and does NOT replace the routine immunization schedule. - According to the **Indian National Immunization Schedule**, the routine first dose of measles vaccine (MR vaccine) is given at **9 months of age**, regardless of whether an earlier outbreak dose was administered. - Vaccines given before 9 months have **reduced efficacy** due to interference from maternal antibodies, making the 9-month dose essential for adequate seroconversion. - After the 9-month dose, a second dose is given at **16-24 months** as per routine schedule. *When the child completes fifteen months of age* - While 15-18 months is appropriate timing for the **second dose** of measles vaccine in the routine schedule, it is not the immediate next dose after a 7-month outbreak vaccination. - The child still requires the **routine 9-month dose first**, followed by the second dose at 16-24 months. - Skipping the 9-month dose and going directly to 15 months would leave a prolonged gap without adequate protection. *Not required* - This is **incorrect** because early doses given before 9 months are considered zero-doses and do not provide reliable long-term immunity. - The routine schedule **must still be followed** to ensure proper immunization, starting with the 9-month dose. *After four weeks* - A four-week interval after the 7-month dose is **too short** and not recommended in immunization guidelines. - There is **no indication** for such an early repeat dose; the child should wait until the routine 9-month schedule for the next dose.
Question 10: As per the Government of India guidelines, the daily dose of elemental iron recommended for prophylaxis during pregnancy is
- A. 150 mg/day for 100 days
- B. 200 mg/day for 100 days
- C. 100 mg/day for 100 days (Correct Answer)
- D. 50 mg/day for 100 days
Explanation: ***100 mg/day for 100 days*** - As per the **Government of India guidelines**, the recommended daily dose of **elemental iron** for prophylaxis during pregnancy is 100 mg/day. - This dose is typically continued for at least **100 days** to ensure adequate iron stores and prevent iron deficiency anemia. *150 mg/day for 100 days* - This dose exceeds the **recommended daily prophylactic** amount of elemental iron specified by Indian government guidelines. - While higher doses may be used for **therapeutic treatment** of existing iron deficiency anemia, it is not the standard for prophylaxis. *200 mg/day for 100 days* - This amount is significantly higher than the standard **prophylactic recommendation** for elemental iron during pregnancy in India. - Such a high dose would typically only be prescribed for **treating severe anemia**, not for routine prevention. *50 mg/day for 100 days* - This dose is lower than the **recommended daily amount** for effective iron prophylaxis according to the Government of India guidelines. - Such a dose might be **insufficient** to maintain adequate iron levels and prevent anemia during pregnancy.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free